Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandospirone + AAPDs for Cognitive Function in Schizophrenia
NCT02040883Phase 4Unknown
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tandospirone in schizophrenia. Status: unknown.
02
Drugs
tandospirone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02040883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040883.